References
- World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections – 2008 Geneva: WHO Press; 2012 [7 January 2014]. Available from: http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf
- Lewis DA. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect 2003;79(1):68–71.
- Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect 2002;78(2):90–2.
- Hook EW, 3rd. A new look at genital herpes: the critical role of the laboratory in diagnosis and management. MLO Med Lab Obs 2012;44(7):8, 10, 2; quiz 20.
- Van Der Pol B, Warren T, Taylor SN, et al. Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol 2012;50(11):3466–71.
- Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2–seropositive persons: a meta-analysis. J Infect Dis 2002;185(1):45–52.
- Tanton C, Weiss HA, Le Goff J, et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One. 2011;6(3): e17480.
- Read PJ, Donovan B. Clinical aspects of adult syphilis. Intern Med J 2012;42(6):614–20.
- Gomez GB, Kamb ML, Newman LM, et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013;91(3):217–26.
- Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect 2010;16(8):1062–9.
- Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26(1): 73–9.
- Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008;197(4): 548–54.
- Mavedzenge SN, Van Der Pol B, Weiss HA, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 2012;26(5):617–24.
- Rivers CA, Adaramola OO, Schwebke JR. Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic. Sex Transm Dis 2011;38(7):672–4.
- Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012;50(8):2601–8.
- Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis 2013;40:97–102. doi:10.1097/OLQ.0b013e31827bd637
- Peeling RW, Mabey D, Herring A, et al. Why do we need quality-assured diagnostic tests for sexually transmitted infections? Nat Rev Microbiol 2006;4(12 Suppl.):S7–19.
- Hurly DS, Buhrer-Skinner M, Badman SG, et al. Field evaluation of the CRT and ACON chlamydia point-of-care tests in a tropical, low-resource setting. Sex Transm Infect 2014;90:179–84. doi: 10.1136/sextrans–2013–051246
- Bolan GA, Sparling, PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med 2012;366(6):485–7.
- Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev 2011;24(3):498–514.